(Q35573819)

8 August 2017

title

Cell transfer therapy for cancer: lessons from sequential treatments of a patient with metastatic melanoma (English)

1 reference

8 August 2017

1 reference

1 reference

1

Steven A Rosenberg

1 reference

8 August 2017

5

Patrick Hwu

1 reference

8 August 2017

8

Suzanne L Topalian

1 reference

8 August 2017

James C Yang

2

1 reference

8 August 2017

Paul F Robbins

3

1 reference

8 August 2017

John R Wunderlich

4

1 reference

8 August 2017

Richard M Sherry

6

1 reference

8 August 2017

Douglas J Schwartzentruber

7

1 reference

8 August 2017

Nicholas P Restifo

9

1 reference

8 August 2017

Armando Filie

10

1 reference

8 August 2017

Richard Chang

11

1 reference

8 August 2017

Mark E Dudley

12

1 reference

8 August 2017

publication date

1 September 2003

1 reference

8 August 2017

number of pages

9

1 reference

inferred from page(s)

published in

Journal of Immunotherapy

1 reference

8 August 2017

volume

26

1 reference

8 August 2017

issue

5

1 reference

8 August 2017

page(s)

385-393

1 reference

Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells

8 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1764125

Natural selection of tumor variants in the generation of "tumor escape" phenotypes

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1764125

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1764125

A phase I study of nonmyeloablative chemotherapy and adoptive transfer of autologous tumor antigen-specific T lymphocytes in patients with metastatic melanoma

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1764125

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1764125

Loss of functional beta 2-microglobulin in metastatic melanomas from five patients receiving immunotherapy

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1764125

The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1764125

Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2

27 July 2018

1 reference

12 December 2020

Evaluation of fludarabine phosphate in malignant melanoma. A Southwest Oncology Group study

1 reference

12 December 2020

Localization of 111indium-labeled tumor infiltrating lymphocytes to tumor in patients receiving adoptive immunotherapy. Augmentation with cyclophosphamide and correlation with response

1 reference

12 December 2020

Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2

1 reference

12 December 2020

Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor

1 reference

12 December 2020

Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma

1 reference

12 December 2020

T-cell clones from melanoma patients immunized against an anchor-modified gp100 peptide display discordant effector phenotypes

1 reference

12 December 2020

Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation

1 reference

12 December 2020

Decreased tolerance to interleukin-2 with repeated courses of therapy in patients with metastatic melanoma or renal cell cancer

1 reference

12 December 2020

10.1097/00002371-200309000-00001

Identifiers

DOI

1 reference

8 August 2017

1 reference

8 August 2017

1 reference